跳至主要内容
临床试验/ACTRN12614000732684
ACTRN12614000732684已完成4 期

The effect of omega-3 supplementation on adverse cardiovascular (CV) events among Indigenous Australians with stable coronary artery disease: A randomized controlled trial

South Australian Health and Medical Research Institute0 个研究点目标入组 220 人开始时间: 2014年7月10日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
220

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • * Men or women, self-identified as Indigenous
  • * Aged over 18 years
  • * Have confirmed Coronary Artery Disease [CAD] (according to nationally consistent definitions):
  • * Prior hospitalisation for myocardial infarction/acute coronary syndrome
  • * Prior revascularisation
  • * Proven coronary stenosis >50%

排除标准

  • * Non-residents of South Australia or Alice Springs, NT.
  • * Patients with significant neurological/cognitive impairment that prevents consent
  • * Hypersensitivity or documented allergy to the study drug
  • * Known bleeding disorder or end-stage renal disease requiring dialysis

研究者

相似试验